ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 68 filers reported holding ADC THERAPEUTICS SA in Q3 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,847,831 | -22.8% | 2,824,956 | -3.1% | 0.01% | -28.6% |
| Q3 2022 | $14,051,000 | -40.3% | 2,915,160 | -1.6% | 0.01% | -36.4% |
| Q2 2022 | $23,545,000 | -45.8% | 2,961,624 | +0.2% | 0.01% | -35.3% |
| Q1 2022 | $43,439,000 | -23.4% | 2,957,056 | +5.3% | 0.02% | -15.0% |
| Q4 2021 | $56,716,000 | -21.3% | 2,807,723 | +5.8% | 0.02% | -28.6% |
| Q3 2021 | $72,089,000 | -3.0% | 2,654,217 | -13.1% | 0.03% | -6.7% |
| Q2 2021 | $74,347,000 | +15.8% | 3,053,248 | +16.1% | 0.03% | +7.1% |
| Q1 2021 | $64,210,000 | +11.4% | 2,630,491 | +46.1% | 0.03% | +3.7% |
| Q4 2020 | $57,642,000 | +34.6% | 1,800,736 | +38.7% | 0.03% | +17.4% |
| Q3 2020 | $42,840,000 | -1.3% | 1,298,565 | +40.0% | 0.02% | -11.5% |
| Q2 2020 | $43,420,000 | – | 927,577 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |